Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions
Polycystic ovary syndrome (PCOS) is a very common endocrine and metabolic disorder with
the involvement of both genetic and environmental factors. Although much has been …
the involvement of both genetic and environmental factors. Although much has been …
Poly cystic ovarian syndrome: an updated overview
S El Hayek, L Bitar, LH Hamdar, FG Mirza… - Frontiers in …, 2016 - frontiersin.org
Poly Cystic Ovarian Syndrome (PCOS) is one of the most common metabolic and
reproductive disorders among women of reproductive age. Women suffering from PCOS …
reproductive disorders among women of reproductive age. Women suffering from PCOS …
[HTML][HTML] Polycystic ovarian syndrome-current pharmacotherapy and clinical implications
Polycystic ovary syndrome (PCOS), the most common endocrinopathy in women is
characterized by polycystic ovaries, chronic anovulation and hyperandrogenism. The …
characterized by polycystic ovaries, chronic anovulation and hyperandrogenism. The …
Inositols in PCOS
Z Kamenov, A Gateva - Molecules, 2020 - mdpi.com
(1) Background: Myoinositol (MI) and D-chiro-inositol (DCI) are involved in a number of
biochemical pathways within oocytes having a role in oocyte maturation, fertilization …
biochemical pathways within oocytes having a role in oocyte maturation, fertilization …
Antioxidants for female subfertility
MG Showell, R Mackenzie-Proctor… - … of systematic reviews, 2020 - cochranelibrary.com
Background A couple may be considered to have fertility problems if they have been trying
to conceive for over a year with no success. This may affect up to a quarter of all couples …
to conceive for over a year with no success. This may affect up to a quarter of all couples …
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
V Unfer, F Facchinetti, B Orrù, B Giordani… - Endocrine …, 2017 - ec.bioscientifica.com
Myo-inositol (MI) supplementation in women with polycystic ovary syndrome (PCOS) has
been evaluated over the last years. Many hormonal and reproductive impairments …
been evaluated over the last years. Many hormonal and reproductive impairments …
Pharmacodynamics and pharmacokinetics of inositol (s) in health and disease
M Bizzarri, A Fuso, S Dinicola, A Cucina… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Inositol and its derivatives comprise a huge field of biology. Myo-inositol is not
only a prominent component of membrane-incorporated phosphatidylinositol, but …
only a prominent component of membrane-incorporated phosphatidylinositol, but …
Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach
Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin second messengers, and MI is
involved in follicular gonadotropin pathways which orchestrate ovulation. The tissue-specific …
involved in follicular gonadotropin pathways which orchestrate ovulation. The tissue-specific …
Effects of inositol (s) in women with PCOS: a systematic review of randomized controlled trials
V Unfer, JE Nestler, ZA Kamenov… - International journal …, 2016 - Wiley Online Library
Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with complex etiology
and pathophysiology, which remains poorly understood. It affects about 5–10% of women of …
and pathophysiology, which remains poorly understood. It affects about 5–10% of women of …